Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial
2003 · Biological Psychiatry · 192 citations
https://doi.org/10.1016/s0006-3223(03)00524-9
O
Olli‐Pekka Ryynänen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
3.0K
Citations
29
h-index
50
i10-index
Olli‐Pekka Ryynänen is an academic researcher from University of Eastern Finland. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Healthcare Policy and Management & Substance Abuse Treatment and Outcomes. The author has an h-index of 29, co-authored 91 publications.
ORCID: 0000-0002-9253-7491Papers by this author
worksBayesian predictors of very poor health related quality of life and mortality in patients with COPD
2013 · BMC Medical Informatics and Decision Making · 31 citations
https://doi.org/10.1186/1472-6947-13-34
Predicting hospital associated disability from imbalanced data using supervised learning
2018 · Artificial Intelligence in Medicine · 31 citations
https://doi.org/10.1016/j.artmed.2018.09.004
Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study
2010 · Critical Care · 16 citations
https://doi.org/10.1186/cc8988
Primary-care-based episodes of care and their costs in a three-month follow-up in Finland
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.1626647
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat